Background: In animals with XY sex chromosomes, X-linked genes from a single X 12 chromosome in males are imbalanced relative to autosomal genes. To minimize the impact of 13 genic imbalance in male Drosophila, there is a dosage compensation complex (MSL), that 14 equilibrates X-linked gene expression with the autosomes. There are other potential 15 contributions to dosage compensation. Hemizygous autosomal genes located in repressive 16 chromatin domains are often de-repressed. If this homolog-dependent repression occurs on the 17 X, which has no pairing partner, then de-repression could contribute to male dosage 18 compensation. 19
To determine the overall structure of chromatin domains on the X, we used results from three 103 previous studies that divided genome into repressive vs. non-repressive chromatin 104 domains/TADs and LADs vs. non-LADs. LAD and DamID (DNA adenine methyltransferase 105
Identification) based chromatin occupancy information was from Kc cells [33, 34] . TAD 106 information was from Hi-C conformation capture from mixed sex embryos [35] . From the Hi-C 107 study, "Null" TADs were characterized by general lack of chromatin marks, except for a weakly 108 enriched binding of an insulator protein, Suppressor of Hairy-wing [SU(HW)]. The LAD and 109 "Null" TADs correspond and largely overlap with "Black" domain DamID work. The "Black" 110 domain has increased signals of Histone H1, Effete (EFF), Suppressor of Under-Replication 111 (SUUR) and Lamin B protein binding. These repressive TADs are known to share various 112 characteristics [35] , and there are significant overlaps among the identified gene sets ( Figure  113 1A). For example, 63% of genes that are in LADs are also in Black domains, and 78% of genes 114 that are in Black domains are in Null domains. We collectively refer to these overlapping 115 domains as "repressive TADs". 116 117 Each of these three repressive TADs covered 23 to 47% of the protein-coding genes in the 118 Drosophila genome. To describe which genes on the X were in repressive TADs, we parsed by 119 chromosome (Figure 1B) . Collectively, genes within LADs included 38% of X chromosome 120 genes and 29% of autosomal genes (p = 1.19e-06, Fisher's exact test). Genes within Null 121 domains included 45% of X chromosome genes and 47% of autosomal genes (p = 0.25). 122
Genes within Black domains included 33% of X chromosome genes and 35% of autosomal 123 genes (p = 0.076). Clearly, a large fraction of the genome, including the X, are in repressive 124 domains. If these genes are simply "off", then asking if they are dosage compensated is a futile 125 contrast to expression levels in the repressive TADs from Kc cells, where LAD and Black 137 domains were determined (Figure 1C -E, the top panel). The median gene expression level was 138 9.1 FPKM for genes within LADs and 16.1 FPKM for genes within Null domains. Genes in 139
Black domains showed lower expression at a median of 2.8 FPKM, but all of these expression 140 levels far exceed our estimates of noise. In Kc cells, approximately 19.6% and 40.4% of the X-141 linked genes demonstrate gene expression above the cutoff levels from LAD and Null domains, 142 respectively. Only 5.7% of the X-linked genes were expressed from Black domains, indicating 143 that the Black domain has the most repressive characteristics among three different calls of 144 repressive TADs. Autosomal genes from repressive TADs also displayed lower gene 145 expression levels compared to non-repressive TAD genes with 9.7 (LAD), 16.1 (Null), and 2.7 146 FPKMs (Black), which are not significantly different from repressive TAD genes on the X (p > 147 0.2, Mann-Whitney U test). In male S2 cells, the repressive TAD genes demonstrated 9.8 148 (LAD), 15.4 (Null), and 5.1 FPKMs (Black), underscoring that repressive TAD genes on the X 149 have comparable expression levels between S2 and Kc cells (p > 0.05, Figure 1C -E), and are 150 thus dosage compensated. We made a similar observation from sexed salivary glands. A large 151 fraction of genes from repressive TADs showed higher expression than the technical noise 152 level, which we determined based on backgrounds signals from the control probes of 153 microarrays ( Figure 1F -H, normalized intensities of approximately 2.3 in both sexes). For 154 example, about 27.4% and 26.6% of the total X-linked LAD genes showed gene expression 155 above the background levels in female and male salivary glands, respectively. Thus, we were 156 confident that we could make meaningful measurements of dosage compensation among those 157 genes. Briefly, a substantial portion of the genes in repressive TAD domains showed detectable 158 levels of gene expression. We used these genes in our analysis. 159
160
Genes in repressive TADs demonstrated comparable expression levels between female (Kc) 161 and male (S2) cells from the X (Figure 1C-E) , indicating that they are dosage compensated. To 162 confirm that male X-linked genes are dosage compensated in repressive TADs, we compared 163 expression profiles from salivary glands, where female and male were matched siblings. From 164 microarray results, we observed that male X-linked genes from LAD regions demonstrated 165 comparable expression levels to that of females ( Figure 1I) . The median signal intensity from 166 male X-linked genes was 3.41, which did not differ from that of female (3.58, p = 0.917) despite 167 the 50% difference in X gene dose. We obtained similar equilibrated expression of the X from 168 other repressive TADs. X chromosome genes in the Null domains showed a median of 5.51 169 signal intensity in X males when it was 5.31 in XX females. Black domain genes had medians 170 of 2.68 and 2.64 signal intensities in X males and XX females, respectively. Overall gene 171 expression signals from autosomes were consistent between two sexes (6.52, p > 0.996 for 172 differential expression Strikingly, in male S2 cells, MOF binding in X chromosome repressive TADs was significantly 187 lower than elsewhere on the X (p < 6.01e-4) and was comparable to occupancy levels on the X 188 in female Kc cells (Figure 2A-C) . H4K16Ac enrichment concurred with MOF occupancy. In all 189 classes of X chromosome repressive TADs, H4K16Ac levels were significantly lower than in 190 other domains (p < 6.96e-09, Figure 2D -F). H4K16Ac levels on X-linked genes was still higher 191 in S2 cells than Kc cells even within repressive TADs (p < 3.02e-09). However, the differences 192 in H4K16Ac levels between male and female cells were significantly smaller in LAD and Null 193 domains than non-repressive TADs on the X (p < 7.14e-04, Permutation test). The Black 194 domain genes showed the same trend, although this was not statistically significant (p = 0.27). disrupted MSL complex function on X-linked genes in repressive TAD domains, we analyzed 238 gene expression profiles of S2 cells whose MSL components were selectively depleted via 239
RNAi-mediated knockdown [36, 41, 42] . When mof mRNA was depleted, X-linked genes within 240
LADs displayed significantly less gene expression reduction; approximately 1.2 fold higher than 241 genes in non-LAD domains (p = 1.1e-13, Mann-Whitney U test, Figure 3A ). We made similar 242 observations from X chromosome genes that belong to Null and Black domains from the Hi-C 243 study and occupancy study. They exhibited about 1.1 to 1.3 fold more expression upon the 244 depletion of mof than other X-linked genes in non-repressive domains (p < 2.3e-08). As 245 expected, those chromatin regions that lack MOF binding and H4K16Ac were less sensitive to 246 the RNAi treatment as well. Genes from regions without enrichment of MOF or H4K16Ac 247 showed 1.2 fold more expression than the enriched regions (p = 1.1e-14 for MOF, and 0.11 for 248 the acetylation). MOF is also bound to sites on autosomes as a part of NSL complex, while it 249 activates only a small subset of genes that the complex binds to [43] . Consistent with this idea, 250
we saw little down-regulation of overall autosomal gene expression from the mof depleted S2 251 cells (p > 0.05, Figure 3B ). 252
253
We also asked if the expression of X-linked genes in repressive TADs was less sensitive to 254 depletion of other MSL components. Our analysis showed significantly less reduction in [44,45]. When we analyzed an independent study that performed RNA-Seq analysis of either 261 mof or msl-2 depleted S2 cells, we also observed about 1.1 fold more expression from the X-262 linked genes within repressive TADs compared to non-repressive TADs (p < 0.001, Figure 3I -263 L). Therefore, results from the MSL knockdown were consistent with our observation in Figure  264 2 and suggest that repressive TAD genes on the X chromosome do not rely entirely on MSL 265 complex for dosage compensation. (CG8675 and CG2875), we noticed that MOF also bound at the 3' ends of genes. Furthermore, 283
H4K16Ac enrichment had peaks at the 3' ends as well, which contrasted with the promoter-284 focused peaks from NSL-MOF target genes (RpL32, Figure 4A ), suggesting that there was 285 some residual MSL activity, rather than NSL. The overall insensitivity to MSL RNAi-depletion 286 suggests that the dosage compensation of these genes does not rely on the MSL complex, but 287 requires additional mechanisms, such as de-repression. asking if knockdown of MSL components had a greate effect on repressive TADs domains 320 specific to male S2 cells (IT). However, this was not the case. Instead, we observed that the 321 genes within repressive TAD domains and boundaries whose TAD locations were well-matched 322 between the two cell lines (TT and II) were better compensated than the others (TI and IT) after 323 depleting MSL components (Figure 5E-G) . For example, LAD-associated genes from TT or II 324 class regions demonstrated excellent dosage compensation after msl-2 knockdown compared 325 to the same genes from the control RNAi samples (0.94 fold, p = 0.047, Mann-Whitney U test, 326 Figure 5E ). We observed the same trend when we looked at genes from Null and Black 327 domains (Figure 5F,G) . In conclusion, these results suggest that our observation of non-328 canonical dosage compensation is not due to sex-specific modification of large TAD structures 329 between male and female cells. TAD that differ between female Kc and male S2 cells may be 330 due to the rearrangements in these highly aneuploid cells, not differences in sexual identity. (Figure 6A,B) . These data suggest 345 that repressive domains are established, strengthened, or stabilized by the existence of 346 homologous pairs of chromosomes. There is strong precedent for pairing-dependent 347 mechanisms in D. melanogaster that are known to activate or repress genes when homologous 348 chromosomes are proximally located [29] [30] [31] [32] . We suggest that the unpaired X chromosomes of 349 males have weaker repressive domains than the same domains in the paired X chromosomes 350 of females (Figure 6C,D There is a clear depletion of genes with male biased expression in regions of high MSL 387 occupancy [61], but given that these specific MSL sites do not appear to be used in the male 388 germline, the suggestion that MSL drives these genes to other locations seems spurious. We 389 have shown that the regions without MSL entries sites correspond to the repressive TADs. 390
Thus, we propose that X-linked genes with male germline functions are more likely to be in 391 repressive TADs, where they can show increased expression as a result of de-repression. 392
Indeed, in our previous results from gene expression profiling of hemizygote files with 393 autosomal deletions [28], we observed that genes with male-biased expression are de-394 repressed in females. There has been strong evolutionary pressure to relocate genes with male 395 germline function off the X chromosomes [62-64]. Those that remain might use de-repression 396 to achieve high expression even on the single X. Our results collectively suggest that MSL complex-independent X chromosome dosage 401 compensation exists in Drosophila melanogaster. We suggest that this non-canonical dosage 402 compensation mechanism involves de-repression of one-dose X chromosome genes in males, 403 which are repressed in their two-dose state in females. Our results have an implication for the X 404 chromosome dosage compensation mechanism before the evolution of the MSL complex. We used mof, msl-1, msl-3 knockdown results from a microarray study [36] , ArrayExpress E-464
MEXP-1505). For the estimation of gene expression changes, we used Robust Multi-array 465
Average (RMA, [75] method for background adjustment and normalization, and filtered out 466 genes of which FPKM value is less than 1 from the S2 cell RNA-Seq result [37] . We use R 467 limma package version 3.28.21 [76] as in the official manual for our differential expression 468 analysis. We obtained the microarray study of the msl-2 knockdown data from [41] . We 469 conducted same data handling process as above. We also re-analyzed RNA-Seq results from 470
[42] (GEO GSE16344). We used HISAT 2.0.4 [77] for the mapping of sequencing reads to 471
Drosophila genome release 5. We used a parameter for unpaired sequencing (-U) in running 472 HISAT. We measured gene-level read abundances with HTSeq 0.6.1 [77] with the default 473 setting. From the counting result, we used polyA + protein coding genes that have more than 1 
S2 cells MOF binding

Kc cells
S2 cells H4K16 Acetylation
S2 cells MSL-1 binding
Female
Salivary Gland 
Male Salivary Gland MOF binding
